Given the recent insight that not activation of CD4+ and CD8+ T cells via TCR, but instead TLR activation, release of type I IFNs and expression of IFNα/β inducible genes may contribute more to systemic immune activation in HIV infection, the latter proteins and genes may be more relevant targets for therapeutic interventions (Figure 1). This evidence concerns the gene CD8A and HIV infectious disease.